La Jolla Pharmaceutical (LJPC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LJPC Annual Balance Sheets →
The balance sheet data below highlights changes in La Jolla Pharmaceutical's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Assets
Cash & cash equivalent48.34
Short-term Investments, Total0.32
Cash & Short-term Investments48.00
Accounts receivable5.93
Inventories8.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.47
Total Current Assets66.36
Equipment/Property/Plant Net0.07
Goodwill net20.12
Intangible Assets12.55
Other Assets, Noncurrent0.27
Total Assets99.37
Liabilities
Accounts Payable, Current AC2.13
Accrued Liabilities, Current AC5.67
Other Liabilities, Current8.70
Total Current Liabilities16.49
Total Long-term Debt0.00
Other liabilities, Noncurrent152.34
Total Liabilities168.83
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock981.25
Retained Earnings / Accumulated Deficit-1,054.63
Other Equity0.00
Common Stockholder's Equity-73.38
Preferred Stockholder's Equity3.91
Total Stockholder's Equity-69.47
Liabilities & Stockholder's Equity99.37
4 historic quarters locked

Sign in to unlock the full La Jolla Pharmaceutical balance sheet history.

About La Jolla Pharmaceutical Co Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001564590-22-029398

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.